• 4754 Citations
  • 38 h-Index
1980 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

An elective course in lesbian, gay, bisexual, and transgender health and practice issues

Jann, M. W., Penzak, S., White, A. & Tatachar, A., 1 Jan 2019, In : American journal of pharmaceutical education. 83, 8, p. 1723-1731 9 p., 6967.

Research output: Contribution to journalArticle

2015
22 Scopus citations
2014

Benzodiazepines: A major component in unintentional prescription drug overdoses with opioid analgesics

Jann, M., Kennedy, W. K. & Lopez, G., Feb 2014, In : Journal of Pharmacy Practice. 27, 1, p. 5-16 12 p.

Research output: Contribution to journalArticle

111 Scopus citations

Unique collaboration between a private college of pharmacy and a private academic health system

Metzger, N., Paciullo, C., Chesson, M., Jann, M. W., Glascock, J., Emamifar, A. & Matthews, H. W., 1 Jan 2014, In : Hospital Pharmacy. 49, 7, p. 634-638 5 p.

Research output: Contribution to journalArticle

1 Scopus citations
2013
38 Scopus citations
2012

Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir

Jann, M. W., Spratlin, V., Momary, K., Zhang, H., Turner, D., Penzak, S. R., Wright, A. & VanDenBerg, C., 1 May 2012, In : European Journal of Clinical Pharmacology. 68, 5, p. 715-721 7 p.

Research output: Contribution to journalArticle

7 Scopus citations
2011

Maternal treatment with opioid analgesics and risk for birth defects

Broussard, C. S., Rasmussen, S. A., Reefhuis, J., Friedman, J. M., Jann, M. W., Riehle-Colarusso, T. & Honein, M. A., 1 Jan 2011, In : American Journal of Obstetrics and Gynecology. 204, 4, p. 314.e1-314.e11

Research output: Contribution to journalArticle

182 Scopus citations
2008

Disposition of D-serine in healthy adults

Tsai, G. E., Lane, H. Y., Vandenberg, C. M., Liu, Y. C., Tsai, P. & Jann, M. W., 1 Apr 2008, In : Journal of Clinical Pharmacology. 48, 4, p. 524-527 4 p.

Research output: Contribution to journalArticle

4 Scopus citations
2006

Altered methylprednisolone pharmacodynamics in healthy subjects with Histamine N-Methyltransferase C314T genetic polymorphism

Yuen, Y. H., Jusko, W. J., Spratlin, V. E. & Jann, M. W., 1 Apr 2006, In : Journal of Clinical Pharmacology. 46, 4, p. 408-417 10 p.

Research output: Contribution to journalArticle

8 Scopus citations

Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells

Matesic, D. F., Abifadel, D. N., Garcia, E. L. & Jann, M. W., 1 Jul 2006, In : Cell Biology and Toxicology. 22, 4, p. 257-268 12 p.

Research output: Contribution to journalArticle

2 Scopus citations

Endogenous histamine and cortisol levels in subjects with different histamine N-methyltransferase C314T genotypes: A pilot study

Yuen, Y. H., Jusko, W. J., Zhou, H. H., Chen, G. L., Guo, D., Zhou, G., Spratlin, V. E. & Jann, M. W., 9 May 2006, In : Molecular Diagnosis and Therapy. 10, 2, p. 109-114 6 p.

Research output: Contribution to journalArticle

6 Scopus citations

Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers

Jann, M. W., Hon, Y. Y., Shamsi, S. A., Zheng, J., Awad, E. A. & Spratlin, V., 1 May 2006, In : Pharmacotherapy. 26, 5 I, p. 627-633 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition

Lee, S. J., Jusko, W. J., Salaita, C. G., Calis, K. A., Jann, M. W., Spratlin, V. E., Goldstein, J. A. & Yuen, Y. H., 1 May 2006, In : Journal of Clinical Pharmacology. 46, 5, p. 515-526 12 p.

Research output: Contribution to journalArticle

11 Scopus citations
2004

Development of capillary zone electrophoresis-electrospray ionization-mass spectrometry for the determination of lamotrigine in human plasma

Zheng, J., Jann, M. W., Hon, Y. Y. & Shamsi, S. A., 1 Jul 2004, In : Electrophoresis. 25, 13, p. 2033-2043 11 p.

Research output: Contribution to journalArticle

43 Scopus citations

Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia

Chiu, C. C., Lane, H. Y., Huang, M. C., Liu, H. C., Jann, M. W., Hon, Y. Y., Chang, W. H. & Lu, M. L., 1 Dec 2004, In : Journal of Clinical Pharmacology. 44, 12, p. 1385-1390 6 p.

Research output: Contribution to journalArticle

21 Scopus citations
2003

Correlation of cytochrome p450 (CYP) ia2 activity using caffeine phenotyping and olanzapine disposition in healthyvolunteers

Shirley, K. L., Hon, Y. Y., Penzak, S. R., Francis Lam, Y. W., Spratlin, V. & Jann, M. W., May 2003, In : Neuropsychopharmacology. 28, 5, p. 961-966 6 p.

Research output: Contribution to journalArticle

49 Scopus citations
2002

Clinical significance of drug binding, protein binding, and binding displacement drug interactions

Jann, M. W., 1 Jun 2002, In : Psychopharmacology bulletin. 36, 3, p. 22-41 20 p.

Research output: Contribution to journalArticle

7 Scopus citations

Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics

Penzak, S. R., Acosta, E. P., Turner, M., Edwards, D. J., Hon, Y. Y., Desai, H. D. & Jann, M. W., 1 Oct 2002, In : Journal of Clinical Pharmacology. 42, 10, p. 1165-1170 6 p.

Research output: Contribution to journalArticle

37 Scopus citations

Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers

Penzak, S. R., Hon, Y. Y., Lawhorn, W. D., Shirley, K. L., Spratlin, V. & Jann, M. W., 5 Aug 2002, In : Journal of Clinical Psychopharmacology. 22, 4, p. 366-370 5 p.

Research output: Contribution to journalArticle

38 Scopus citations

Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype

Jann, M. W., ZumBrunnen, T. L., Kazmi, Y. R., VanDenBerg, C. M., Desai, H. D., Weidler, D. J. & Flockhart, D. A., 9 Oct 2002, In : Drug Metabolism and Drug Interactions. 19, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

12 Scopus citations
2001

Contemporary drug treatment

Corey-Bloom, J., Geldmacher, D. S. & Jann, M. W., 15 Feb 2001, In : Patient Care. 35, 3, p. 54-67 14 p.

Research output: Contribution to journalArticle

Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo

Lane, H. Y., Chiu, C. C., Kazmi, Y., Desai, H., Francis Lam, Y. W., Jann, M. W. & Chang, W. H., 1 Jan 2001, In : Drug Metabolism and Drug Interactions. 18, 3-4, p. 263-278 16 p.

Research output: Contribution to journalArticle

13 Scopus citations

Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability

Lane, H. Y., Jann, M. W., Chang, Y. C., Chiu, C. C., Huang, M. C., Lee, S. H. & Chang, W. H., 1 Jan 2001, In : Journal of Clinical Psychiatry. 62, 10, p. 812-817 6 p.

Research output: Contribution to journalArticle

30 Scopus citations

Seville (sour) orange juice: Synephrine content and cardiovascular effects in normotensive adults

Penzak, S. R., Jann, M. W., Cold, J. A., Hori, Y. Y., Desai, H. D. & Gurley, B. J., 1 Jan 2001, In : Journal of Clinical Pharmacology. 41, 10, p. 1059-1063 5 p.

Research output: Contribution to journalArticle

85 Scopus citations

The Impact of Cloning in Pharmaceutical Products and for Human Therapeutics

Jann, M. W., Shirley, K. L. & Falek, A., 1 Jan 2001, In : Global Bioethics. 14, 2-3, p. 47-51 5 p.

Research output: Contribution to journalArticle

Open Access
2000

An international symposium on psychopharmacology and ethnicity

Jann, M. W. & Montane Jaime, L. K., 1 Jan 2000, In : Drug Metabolism and Drug Interactions. 16, 1, p. 13-14 2 p.

Research output: Contribution to journalArticle

Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice

Aitchison, K. J., Jann, M. W., Zhao, J., Sakai, T., Zaher, H., Wolff, K., Collier, D., Kerwin, R. W. & Gonzalez, F. J., 1 Jan 2000, In : Journal of Psychopharmacology. 14, 4, p. 353-359 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

Disposition of olanzapine in Chinese schizophrenic patients

Lane, H. Y., Liu, H. C., Vandenberg, C. M., Su, M. H., Jann, M. W. & Chang, W. H., 1 Jan 2000, In : International Journal of Clinical Pharmacology and Therapeutics. 38, 10, p. 482-485 4 p.

Research output: Contribution to journalArticle

6 Scopus citations

Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients

Lu, M. L., Lane, H. Y., Chen, K. P., Jann, M. W., Su, M. H. & Chang, W. H., 1 Jan 2000, In : Journal of Clinical Psychiatry. 61, 8, p. 594-599 6 p.

Research output: Contribution to journalArticle

88 Scopus citations

Pharmacogenetics and Pharmacogenomics: Public Policy and Bioethical Issues Associated with Patents for Drug Development

Falek, A. & Jann, M. W., 1 Jan 2000, In : Global Bioethics. 13, 3-4, p. 29-42 14 p.

Research output: Contribution to journalArticle

Open Access

Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion

Vandenberg, C. M., Kazmi, Y., Stewart, J., Weidler, D. J., Tenjarla, S. N., Ward, E. S. & Jann, M. W., 1 Jun 2000, In : American Journal of Health-System Pharmacy. 57, 11, p. 1046-1050 5 p.

Research output: Contribution to journalArticle

18 Scopus citations

Supportive care for the patient with Alzheimer's disease.

Jann, M. W. & Brandt, N., 1 Jan 2000, In : Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 40, 5 Suppl 1

Research output: Contribution to journalArticle

3 Scopus citations
30 Scopus citations
1999

Effects of gender and age on plasma levels of clozapine and its metabolites: Analyzed by critical statistics

Lane, H. Y., Chang, Y. C., Chang, W. H., Lin, S. K., Tseng, Y. T. & Jann, M. W., Jan 1999, In : Journal of Clinical Psychiatry. 60, 1, p. 36-40 5 p.

Research output: Contribution to journalArticle

125 Scopus citations

Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: A randomized, double-masked, placebo-controlled trial

Jann, M. W., Cyrus, P. A., Eisner, L. S., Margolin, D. I., Griffin, T. & Gulanski, B., 1 Jan 1999, In : Clinical Therapeutics. 21, 1, p. 88-102 15 p.

Research output: Contribution to journalArticle

10 Scopus citations

In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine

Chang, W. H., Augustin, B., Lane, H. Y., ZumBrunnen, T., Liu, H. C., Kazmi, Y. & Jann, M. W., 29 Jul 1999, In : Psychopharmacology. 145, 1, p. 91-98 8 p.

Research output: Contribution to journalArticle

41 Scopus citations
1998

Economic considerations and formulary management of oral antipsychotics

Jann, M. W. & Cohen, L. J., 5 May 1998, In : Disease Management and Health Outcomes. 3, 3, p. 115-129 15 p.

Research output: Contribution to journalArticle

9 Scopus citations

Increased lithium serum and red blood cell concentrations during ketorolac coadministration

Cold, J. A., Zumbrunnen, T. L., Simpson, M. A., Augustin, B. G., Awad, E. & Jann, M. W., 1 Feb 1998, In : Journal of Clinical Psychopharmacology. 18, 1, p. 33-37 5 p.

Research output: Contribution to journalArticle

9 Scopus citations

Pharmacology and clinical efficacy of cholinesterase inhibitors

Jann, M. W., 1 Nov 1998, In : American Journal of Health-System Pharmacy. 55, 21 SUPPL., p. S22-S25

Research output: Contribution to journalArticle

23 Scopus citations

Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: Formulation and gender differences

Jann, M. W., ZumBrunnen, T. L., Tenjarla, S. N., Ward, E. S. & Weidler, D. J., 1 Mar 1998, In : Pharmacotherapy. 18, 2 I, p. 288-294 7 p.

Research output: Contribution to journalArticle

20 Scopus citations

Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients

Chang, W. H., Lin, S. K., Lane, H. Y., Wei, F. C., Hu, W. H., Lam, Y. W. F. & Jann, M. W., 1 Jul 1998, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 22, 5, p. 723-739 17 p.

Research output: Contribution to journalArticle

61 Scopus citations
1997

Blood levels of reduced haloperidol versus clinical efficacy and extrapyramidal side effects of haloperidol

Lane, H. Y., Lin, H. N., Hu, O. Y. P., Chen, C. C., Jann, M. W. & Chang, W. H., 1 Feb 1997, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 21, 2, p. 299-311 13 p.

Research output: Contribution to journalArticle

18 Scopus citations

Clozapine dosages and plasma drug concentrations

Chang, W. H., Lin, S. K., Lane, H. Y., Hu, W. H., Jann, M. W. & Lin, H. N., 1 Aug 1997, In : Journal of the Formosan Medical Association. 96, 8, p. 599-605 7 p.

Research output: Contribution to journalArticle

49 Scopus citations

Dextromethorphan phenotyping and haloperidol disposition in schizophrenic patients

Lane, H. Y., Hu, O. Y. P., Jann, M. W., Deng, H. C., Lin, H. N. & Chang, W. H., 24 Mar 1997, In : Psychiatry Research. 69, 2-3, p. 105-111 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

Dose-dependent reduced haloperidol/haloperidol ratios: Influence of patient-related variables

Lane, H. Y., Chang, W. H., Chang, Y. C., Hu, O. Y. P., Lin, H. N., Jann, M. W. & Hu, W. H., 19 Sep 1997, In : Psychiatry Research. 72, 2, p. 127-132 6 p.

Research output: Contribution to journalArticle

6 Scopus citations

Gender differences in plasma clozapine levels and its metabolites in schizophrenic patients

Jann, M. W., Liu, H. C., Wei, F. C., Lin, S. K., Lin, S. K., Hu, W. H. & Chang, W. H., 1 Sep 1997, In : Human Psychopharmacology. 12, 5, p. 489-495 7 p.

Research output: Contribution to journalArticle

17 Scopus citations

In vitro metabolism of clozapine in human hepatic microsomes

Augustin, B. G., Thurston, A., Thomas, G., Hui, J. & Jann, M. W., 1 Dec 1997, In : Clinical Pharmacology and Therapeutics. 61, 2, 1 p.

Research output: Contribution to journalArticle

Plasma alpha-one acid glycoprotein and haloperidol concentrations in schizophrenic patients

Jann, M. W., Crabtree, B. L., Pitts, W. M., Lam, F. & Carter, G., 1 Jan 1997, In : Neuropsychobiology. 36, 1, p. 32-36 5 p.

Research output: Contribution to journalArticle

7 Scopus citations
1996

A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy

Wei, F. C., Jann, M. W., Lin, H. N., Piao-Chien, C. & Chang, W. H., 1 Jul 1996, In : Journal of Clinical Psychiatry. 57, 7, p. 298-302 5 p.

Research output: Contribution to journalArticle

14 Scopus citations

Disposition of remoxipride in Chinese schizophrenic patients

Lin, S. K., Chang, W. H., Chien, C. P., Lam, Y. W. F. & Jann, M. W., 23 Jan 1996, In : International Journal of Clinical Pharmacology and Therapeutics. 34, 1, p. 17-20 4 p.

Research output: Contribution to journalArticle

1 Scopus citations